• Chrysea Labs and nuBioAge announce an exclusive U.S. supply and distribution agreement for Sprevive® spermidine...
– An early-phase clinical study designed to characterise bio-effective dosing in immune and metabolic biomarkers– Investigation of dose–response...
– Chrysea and KaloCyte have entered into an exclusive license agreement, forging a global partnership that...
– At BFLS, significant associations reported in a large representative cohort of 8965 Americans between higher...
– For the first time epidemiology study results define normal dietary intake norms and wide range in...
• Launching of first pure spermidine formulation with GRAS panel endorsement.• Scientifically backed by human...
